Specialized Medical Company (TADAWUL:4019)
Saudi Arabia · Delayed Price · Currency is SAR 16.59
-0.21 (-1.25%)
Jun 11, 2026, 3:19 PM AST
TADAWUL:4019 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 269.14 | 266.23 | 185.22 | 168.7 | 102.96 | 55.97 |
Depreciation & Amortization | 95.96 | 93.05 | 87.48 | 87.76 | 103.94 | 102.94 |
Loss (Gain) From Sale of Assets | -60.49 | -60.49 | 2.29 | 0.02 | -0.06 | -0.05 |
Loss (Gain) From Sale of Investments | 0.81 | 0.39 | - | - | - | - |
Provision & Write-off of Bad Debts | 19.76 | 12.64 | 9.68 | 6.21 | 36.13 | 51.32 |
Other Operating Activities | 51.8 | 56.49 | 48.05 | 56.65 | 34.69 | 23.28 |
Change in Accounts Receivable | -89.57 | -65.37 | 92.16 | -89.05 | -121.1 | -111.96 |
Change in Inventory | -6.14 | -4.4 | 3.19 | -5.89 | -0.79 | 4.56 |
Change in Accounts Payable | 1 | 11.01 | -10.99 | 4.68 | 14.87 | -32.13 |
Change in Other Net Operating Assets | 5.54 | 13.19 | -33.3 | 4.3 | 6.85 | -178.17 |
Operating Cash Flow | 287.8 | 322.74 | 383.78 | 233.37 | 177.48 | -84.25 |
Operating Cash Flow Growth | -36.25% | -15.91% | 64.45% | 31.49% | - | - |
Capital Expenditures | -87.97 | -94.46 | -94.27 | -72.84 | -60.89 | -75.14 |
Sale of Property, Plant & Equipment | 0.04 | 0.04 | 0.93 | 0.84 | 0.06 | 0.2 |
Investment in Securities | -3.13 | -3.13 | - | - | - | - |
Investing Cash Flow | -91.07 | -97.56 | -93.34 | -72 | -60.82 | -74.94 |
Short-Term Debt Issued | - | 658.28 | 760.54 | 20 | 15 | 170 |
Long-Term Debt Issued | - | 200 | - | - | - | 47.71 |
Total Debt Issued | 771.83 | 858.28 | 760.54 | 20 | 15 | 217.71 |
Short-Term Debt Repaid | - | -902.29 | -685 | - | - | - |
Long-Term Debt Repaid | - | -94.52 | -85.51 | -53.44 | -46.96 | -25.84 |
Total Debt Repaid | -895.4 | -996.81 | -770.51 | -53.44 | -46.96 | -25.84 |
Net Debt Issued (Repaid) | -123.56 | -138.53 | -9.98 | -33.44 | -31.96 | 191.88 |
Common Dividends Paid | -200 | - | -200 | -60 | -50 | -35 |
Other Financing Activities | 170.5 | 67.57 | -35.81 | -41.88 | -25.73 | -16.34 |
Financing Cash Flow | -153.06 | -70.97 | -245.78 | -135.33 | -107.69 | 140.54 |
Net Cash Flow | 43.67 | 154.21 | 44.66 | 26.04 | 8.97 | -18.65 |
Free Cash Flow | 199.83 | 228.28 | 289.52 | 160.53 | 116.6 | -159.38 |
Free Cash Flow Growth | -44.84% | -21.15% | 80.35% | 37.68% | - | - |
Free Cash Flow Margin | 12.89% | 14.84% | 20.14% | 11.73% | 9.65% | -15.13% |
Free Cash Flow Per Share | 0.80 | 0.91 | 1.16 | 1.89 | 1.37 | -1.88 |
Cash Interest Paid | 29.5 | 32.43 | 35.81 | 41.88 | 25.73 | 16.34 |
Levered Free Cash Flow | 161.68 | 87.69 | 172.75 | 41.2 | 251.67 | -201.45 |
Unlevered Free Cash Flow | 187.11 | 114.24 | 200.98 | 71.48 | 270.31 | -189.65 |
Change in Working Capital | -89.17 | -45.57 | 51.06 | -85.97 | -100.17 | -317.69 |